Navigation Links
DNA barcoding of mosquito species deployed in bid to end elephantiasis
Date:4/29/2009

New biotechnologies that allow scientists to quickly and accurately distinguish species based on a simple DNA analysis are being creatively deployed for the first time in the war against a major global disease.

The University of Ghana, supported by the Philadelphia-based JRS Biodiversity Foundation, is pioneering the use of DNA "barcodes" to map menacing mosquito species in West Africa that spread lymphatic filariasis (LF), commonly known as elephantiasis. Using a short DNA sequence from a particular genome region, scientists can obtain a species' 'barcode' identity. Barcodes are needed because closely-related species, with different capabilities to transmit LF, are otherwise hard to distinguish.

The ability to precisely identify mosquito species in this way is a promising advance in the battle against LF, an often disfiguring disease that today threatens 1 billion people across roughly 80 countries. Over 120 million people have the parasitic infection and more than 40 million have been permanently disabled or disfigured.

The research is identifying species spreading the worm larvae that clog the human lymph system, often causing grotesque swelling. By revealing the menace species' habitat and range, it also aids understanding of environmental factors that influence their breeding and abundance.

"The scientific breakthrough of DNA barcoding, which grew explosively from a single Canadian research paper in 2003, is shedding new light on LF a horrific and entirely preventable health scourge in developing countries," says principal investigator Prof. Daniel Boakye of the University of Ghana.

"Beyond the immediate battle against this disease in West Africa, the value to human health of these important new tools will grow as the range and habitats of specific mosquito species shift due to climate change."

LF is a leading cause of permanent and long-term disability worldwide and results from a microscopic, thread-like worm spread between humans through a mosquito's bite. Living within a human's blood, the worm larvae grow into adults which mate and produce other larvae, called microfilariae. Symptoms often appear years after infection. The disease can permanently damage the lymph system and kidneys, which results in fluid collecting and swelling in the arms, breasts, legs, and, for men, the genital area. The disease also makes it difficult for the body to fight germs and infections.

Poor sanitation and rapid growth in tropical and subtropical areas has created more places for mosquitoes to breed and thus to more LF infection.

World health authorities have earmarked the disease for eradication by 2020 through mass drug administration (MDA). Officials are identifying communities where LF is endemic and treating people at risk with annual doses of a combination drug therapy (albendazole / DEC or albendazole / ivermectin, freely donated by Merck and Co. and GSK respectively).

The drug reduces the density of worm larvae in humans. This LF elimination strategy relies on a belief that the region's main LF vector, the Anopheles mosquito, is incapable of transmitting low-density worm larvae.

But the Anopheles family is highly diverse and contains hundreds of species. And the new molecular studies reveal that not all Anopheles species are created equal. Some can transmit the disease despite the drugs' thinning of the worm larvae.

The research is pointing out places infested with the menace species and, therefore, where the drug strategy needs to be supplemented with insecticides to successfully eliminate LF.

Prof. Boakye also notes that blanket vector control using insecticides can have serious impact on non-target organisms, leading to biodiversity loss. The additional information and insights into specific mosquito species allows for those species and areas to be targeted, reducing the level of spraying and its effect on other organisms.

"The expertise to create databases is in short supply in Africa; the JRS Foundation is assisting science in very meaningful ways," he says.

The ground-breaking work of the Ghana-based institute is one of 17 JRS-supported projects to be showcased at the e-Biosphere 09 Conference in London June 1-3 (www.e-biosphere09.org), hosted by the Natural History Museum. Co-sponsored by the Encyclopedia of Life and 12 other leading institutions, the event is an exposition of the latest biology-related informatics tools and technologies, as well as their potential linkages and applications.

JRS Board President James L. Edwards, Executive Director of the Encyclopedia of Life, based at the Smithsonian Institution, Washington, DC, says biodiversity information is often compiled for diverse purposes and stored in unique databases using different formats, making the task of effectively using it cumbersome and time-consuming.

The JRS Foundation works to aggregate, digitize, synthesize and make easily available important biodiversity information from developing countries that is often inaccessible to potential users, including conservation managers, policy makers and the public.

"Earth's plant and animal species are declining at an alarming rate. An estimated 50,000 species disappear every year, mostly due to human impacts population growth, industrial development, pollution and climate change," says Dr. Edwards.

"Efforts to stabilize and reverse this trend are hampered by biodiversity knowledge banks that are incomplete, fragmented and not easily accessible to those who need them to set environmental priorities or create informed policies and decisions. In addition, biodiversity databases often cannot share information with each other due to incompatible formats."

"Though endowed only in 2004, the JRS Foundation has already established itself as an important partner of developing-country scientists and organizations working in the new, rapidly growing field of biodiversity informatics," says Dr. Edwards.


'/>"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
JRS Biodiversity Foundation
Source:Eurekalert

Related biology news :

1. Blood testing, mosquito style
2. Malaria immunity trigger found for multiple mosquito species
3. Hoarding rainwater could dramatically expand range of dengue-fever mosquito
4. Mosquitoes create harmonic love song before mating, study finds
5. No more big stink: scent lures mosquitoes, but humans cant smell it
6. Pathway found that lets mosquitoes fatten up, slow down for winter
7. Ayurvedic nightshade deadly for dengue mosquito
8. Netting mosquitoes to prevent malaria
9. Researchers put the bite on mosquitoes
10. Earlier bites by uninfected mosquitoes boost West Nile deaths in lab mice
11. USDA Cooperative Agreement funds mosquito project at Rutgers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 /PRNewswire/ ... sensor-based diagnostic products, today announced the closing of a $9 ... investors.  Proceeds from the financing will be used to accelerate ... device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has been ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
(Date:1/6/2016)... Jan. 6, 2016 Based on its ... & Sullivan recognizes MorphoTrak, LLC, a U.S. subsidiary ... Frost & Sullivan Company of the Year Award. ... technology, Morpho Wave™ , has consolidated the company,s ... biometrics market. Morpho Wave is a highly ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
Breaking Biology Technology: